Oppenheimer Holdings, Inc. Boosts Xylem Inc. (XYL) Price Target to $75.00

Xylem Inc. (NYSE:XYL) had its target price increased by Oppenheimer Holdings, Inc. from $66.00 to $75.00 in a report issued on Wednesday, November 1st. Oppenheimer Holdings, Inc. currently has an outperform rating on the industrial products company’s stock. Oppenheimer Holdings also issued estimates for Xylem’s FY2017 earnings at $2.40 EPS, FY2018 earnings at $2.80 EPS and FY2019 earnings at $3.25 EPS.

Other analysts have also recently issued research reports about the stock. Cowen and Company restated an outperform rating and set a $70.00 target price (up previously from $60.00) on shares of Xylem in a research note on Wednesday, August 9th. Boenning Scattergood restated an outperform rating on shares of Xylem in a research note on Tuesday, September 5th. Royal Bank Of Canada raised their target price on shares of Xylem from $58.00 to $64.00 and gave the stock an outperform rating in a research note on Wednesday, August 2nd. Robert W. Baird restated a hold rating and set a $67.00 target price on shares of Xylem in a research note on Wednesday, October 4th. Finally, Stifel Nicolaus reaffirmed a hold rating and set a $52.00 price target on shares of Xylem in a research report on Thursday, July 6th. Six analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock currently has a consensus rating of Buy and an average target price of $65.17.

Shares of Xylem (NYSE XYL) opened at $66.99 on Wednesday. The company has a market cap of $11,929.03, a price-to-earnings ratio of 29.00, a price-to-earnings-growth ratio of 1.85 and a beta of 1.16. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.76 and a quick ratio of 1.26. Xylem has a 12 month low of $46.67 and a 12 month high of $67.64.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, October 31st. The industrial products company reported $0.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.64 by $0.01. The company had revenue of $1.20 billion during the quarter, compared to analysts’ expectations of $1.18 billion. Xylem had a net margin of 6.85% and a return on equity of 17.74%. Xylem’s quarterly revenue was up 33.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.54 EPS. equities research analysts expect that Xylem will post 2.39 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This article was first published by BBNS and is the sole property of of BBNS. If you are reading this article on another site, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this article can be viewed at https://baseballnewssource.com/markets/oppenheimer-holdings-inc-boosts-xylem-inc-xyl-price-target-to-75-00/1749030.html.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Shareholders of record on Thursday, November 2nd will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 1.07%. The ex-dividend date of this dividend is Wednesday, November 1st. Xylem’s dividend payout ratio is currently 41.86%.

In other Xylem news, insider Colin R. Sabol sold 38,070 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $65.81, for a total value of $2,505,386.70. Following the transaction, the insider now directly owns 61,979 shares of the company’s stock, valued at approximately $4,078,837.99. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Curtis J. Crawford sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $66.44, for a total transaction of $498,300.00. Following the completion of the transaction, the director now directly owns 52,385 shares in the company, valued at $3,480,459.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 83,270 shares of company stock worth $5,501,312. Insiders own 0.75% of the company’s stock.

Several institutional investors have recently made changes to their positions in XYL. USS Investment Management Ltd bought a new stake in shares of Xylem during the 2nd quarter valued at approximately $91,840,000. Janus Henderson Group PLC grew its holdings in shares of Xylem by 404.5% during the 2nd quarter. Janus Henderson Group PLC now owns 1,853,943 shares of the industrial products company’s stock valued at $102,758,000 after purchasing an additional 1,486,463 shares during the last quarter. Voya Investment Management LLC grew its holdings in shares of Xylem by 554.0% during the 2nd quarter. Voya Investment Management LLC now owns 1,242,748 shares of the industrial products company’s stock valued at $68,886,000 after purchasing an additional 1,052,719 shares during the last quarter. William Blair Investment Management LLC bought a new stake in shares of Xylem during the 2nd quarter valued at approximately $48,151,000. Finally, State Street Corp grew its holdings in shares of Xylem by 11.5% during the 2nd quarter. State Street Corp now owns 8,360,506 shares of the industrial products company’s stock valued at $460,211,000 after purchasing an additional 861,484 shares during the last quarter. 87.39% of the stock is currently owned by institutional investors.

Xylem Company Profile

Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.